Kareus Therapeutics enters strategic drug development alliance with Quintiles

Alliance combines innovative drug discovery with world-class development expertise and global infrastructure to expedite clinical proof-of-relevance in two programs

20-Jun-2011 - Kareus Therapeutics SA, a company focused on the development of novel therapeutics to address high unmet medical need, announced a broad strategic alliance with Quintiles to progress the development of two of Kareus’ pre-clinical programs through clinical trials.Under the terms of the alliance, ...

Quintiles, London Genetics ally to enhance drug discovery and development through pharmacogenetics

Alliance combines world-class expertise and global infrastructure to support biopharma in the development of personalized medicine

02-Dec-2010 - Quintiles and London Genetics announced a strategic alliance to offer the biopharmaceutical industry pharmacogenetics solutions to advance personalized medicine. Financial terms were not disclosed. Under the non-exclusive alliance, Quintiles and London Genetics will collaborate to help biopharma ...

Dako and Quintiles form alliance to speed development of personalized medicine

02-Nov-2010 - Dako and Quintiles announced a strategic alliance to advance personalized medicine by collaborating on the co-development of targeted therapies and companion diagnostics. Under the non-exclusive alliance, Dako and Quintiles will offer integrated drug-diagnostic development services and companion ...

Quintiles Opens Expanded Asia-Pacific Headquarters in Singapore

06-Nov-2009 - To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, announced the official grand opening of its expanded regional ...

Quintiles To Open Central Laboratory in Mumbai, India

Expands Laboratory Network to Support Global, Regional Clinical Trials

18-Oct-2006 - Quintiles Transnational Corp. announced plans to open a central lab in Mumbai, India, further expanding the company's global network of labs that support global and regional clinical trials. The new lab, owned and operated by Quintiles, will be equipped and staffed before the end of 2006 and is ...

Virax lodges application to conduct an HIV clinical trial in South Africa

06-Sep-2006 - Virax has lodged a Clinical Trial Application (CTA) with the South African Medicines Control Council (MCC) for approval to conduct a Phase I/IIa trial of the VIR201 HIV vaccine. A group of some of South Africa's leading HIV/AIDS clinicians, led by Dr Des Martin, President of the Southern African ...

Quintiles Extends Asia Operations With Opening of Vietnam Office

05-Dec-2005 - Quintiles Transnational Corp. announced the extension of its Asia operations with the opening of an office in Hanoi, Vietnam. "Vietnam is an increasingly important market in the region, with its population of 80 million, a strong educational system and a robust healthcare industry," said Michael ...